Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 27;10(8):2879.
doi: 10.1016/j.ekir.2025.03.059. eCollection 2025 Aug.

Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes

Liliana Italia De Rosa  1 , Martina Catania  1 , Kristiana Kola  1 , Michele Paolisi  1 , Pierpaolo Bianca  1 , Paolo Manunta  1   2 , Giuseppe Vezzoli  1   2 , Maria Teresa Sciarrone Alibrandi  2
Affiliations

Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes

Liliana Italia De Rosa et al. Kidney Int Rep. .
No abstract available

PubMed Disclaimer

References

    1. Dahl N.K., Torres V.E. What is the appropriate dose of tolvaptan in ADPKD? Kidney Int Rep. 2024;9:737–739. doi: 10.1016/j.ekir.2024.01.049. - DOI - PMC - PubMed
    1. Blair H.A. Tolvaptan: a review in autosomal dominant polycystic kidney disease. Drugs. 2019;79:303–313. doi: 10.1007/s40265-019-1056-1. - DOI - PubMed
    1. Oporto F.J.R., Gómez C.A., Cosano G.M., Aguilera A.L., Rocha J.L. Prospective study on individualized dose adjustment of tolvaptan based on urinary osmolality in patients with ADPKD. Kidney Int Rep. 2024;9:1031–1039. doi: 10.1016/j.ekir.2024.01.020. - DOI - PMC - PubMed
    1. Ivaturi V., Gobburu J., Leslie B., Wang X., Jadhav P. Urine osmolality is a potential marker of longer-term efficacy of tolvaptan in autosomal dominant polycystic kidney disease: a post hoc analysis. Kidney360. 2024;5:996–1001. doi: 10.34067/KID.0000000000000485. - DOI - PMC - PubMed
    1. Delli Zotti G.B., Sangiovanni E., Brioni E., et al. Psychological assessment of a sample of women with ADPKD: quality of life, body image, anxiety and depression. G Ital Nefrol. 2019;36:2019. vol2. - PubMed

LinkOut - more resources